89 related articles for article (PubMed ID: 19798112)
1. Photodynamic therapy for choroidal neovascularisation secondary to basal laminar drusen.
Guigui B; Martinet V; Leveziel N; Coscas G; Soubrane G; Souied EH
Eye (Lond); 2009 Nov; 23(11):2115-8. PubMed ID: 19798112
[TBL] [Abstract][Full Text] [Related]
2. Photodynamic therapy with verteporfin for subfoveal choroidal neovascularisation of pathologic myopia in Chinese eyes: a prospective series of 1 and 2 year follow up.
Lam DS; Chan WM; Liu DT; Fan DS; Lai WW; Chong KK
Br J Ophthalmol; 2004 Oct; 88(10):1315-9. PubMed ID: 15377558
[TBL] [Abstract][Full Text] [Related]
3. Photodynamic therapy for choroidal neovascular membrane secondary to optic nerve drusen.
Chaudhry NA; Lavaque AJ; Shah A; Liggett PE
Ophthalmic Surg Lasers Imaging; 2005; 36(1):70-2. PubMed ID: 15688974
[TBL] [Abstract][Full Text] [Related]
4. Verteporfin photodynamic therapy of choroidal neovascularization in angioid streaks: one-year results of a prospective case series.
Browning AC; Chung AK; Ghanchi F; Harding SP; Musadiq M; Talks SJ; Yang YC; Amoaku WM;
Ophthalmology; 2005 Jul; 112(7):1227-31. PubMed ID: 15921757
[TBL] [Abstract][Full Text] [Related]
5. Bilateral CNV associated with optic nerve drusen treated with photodynamic therapy with verteporfin.
Silva R; Torrent T; Loureiro R; Travassos A; de Abreu JR
Eur J Ophthalmol; 2004; 14(5):434-7. PubMed ID: 15506607
[TBL] [Abstract][Full Text] [Related]
6. Verteporfin photodynamic therapy in highly myopic subfoveal choroidal neovascularisation.
Montero JA; Ruiz-Moreno JM
Br J Ophthalmol; 2003 Feb; 87(2):173-6. PubMed ID: 12543746
[TBL] [Abstract][Full Text] [Related]
7. Photodynamic therapy of subfoveal choroidal neovascularization in age-related macular degeneration with verteporfin: one-year results of 2 randomized clinical trials--TAP report. Treatment of age-related macular degeneration with photodynamic therapy (TAP) Study Group.
Arch Ophthalmol; 1999 Oct; 117(10):1329-45. PubMed ID: 10532441
[TBL] [Abstract][Full Text] [Related]
8. Photodynamic therapy with verteporfin in mallatia leventinese.
Dantas MA; Slakter JS; Negrao S; Fonseca RA; Kaga T; Yannuzzi LA
Ophthalmology; 2002 Feb; 109(2):296-301. PubMed ID: 11825812
[TBL] [Abstract][Full Text] [Related]
9. Photodynamic therapy of idiopathic and inflammatory choroidal neovascularization in young adults.
Rogers AH; Duker JS; Nichols N; Baker BJ
Ophthalmology; 2003 Jul; 110(7):1315-20. PubMed ID: 12867384
[TBL] [Abstract][Full Text] [Related]
10. Combined photodynamic therapy with verteporfin and intravitreal triamcinolone acetonide for choroidal neovascularization.
Spaide RF; Sorenson J; Maranan L
Ophthalmology; 2003 Aug; 110(8):1517-25. PubMed ID: 12917166
[TBL] [Abstract][Full Text] [Related]
11. Verteporfin photodynamic therapy for extrafoveal choroidal neovascularisation in pathologic myopia.
Gelisken F; Inhoffen W; Hermann A; Grisanti S; Bartz-Schmidt KU
Graefes Arch Clin Exp Ophthalmol; 2004 Nov; 242(11):926-30. PubMed ID: 15258776
[TBL] [Abstract][Full Text] [Related]
12. Photodynamic therapy with verteporfin following transpupillary thermotherapy for CNV evolving from an initially occult to a predominantly classic form, in patients with AMD.
Hamon F; Goeminne P
Semin Ophthalmol; 2001 Dec; 16(4):223-32. PubMed ID: 15513445
[TBL] [Abstract][Full Text] [Related]
13. Photodynamic therapy with verteporfin for subfoveal choroidal neovascularization in age-related macular degeneration: results of an effectiveness study.
Sharma S; Bakal J; Oliver-Fernandez A; Blair J
Arch Ophthalmol; 2004 Jun; 122(6):853-6. PubMed ID: 15197060
[TBL] [Abstract][Full Text] [Related]
14. 12-month retrospective study and review of photodynamic therapy with verteporfin for subfoveal choroidal neovascularization in age-related macular degeneration.
Incorvaia C; Campa C; Parmeggiani F; Menzione M; D'Angelo S; Della Corte M; Rinaldi M; Romano M; Dell'omo R; Costagliola C
Retina; 2008 Feb; 28(2):289-97. PubMed ID: 18301052
[TBL] [Abstract][Full Text] [Related]
15. Photodynamic therapy with verteporfin for subfoveal choroidal neovascularization secondary to pathologic myopia: long-term study.
Pece A; Isola V; Vadalà M; Matranga D
Retina; 2006 Sep; 26(7):746-51. PubMed ID: 16963846
[TBL] [Abstract][Full Text] [Related]
16. Verteporfin therapy for myopic choroidal neovascularisation in Indian eyes (one year results).
Hussain N; Das T; Vashist U; Sumashri K
Indian J Ophthalmol; 2004 Sep; 52(3):227-31. PubMed ID: 15510463
[TBL] [Abstract][Full Text] [Related]
17. Photodynamic therapy with verteporfin for choroidal neovascularization due to age-related macular degeneration and other causes: a New Zealand outcomes study.
Sharp DM; Lai S; Markey CM
Clin Exp Ophthalmol; 2007; 35(1):24-31. PubMed ID: 17300567
[TBL] [Abstract][Full Text] [Related]
18. Photodynamic therapy of subfoveal choroidal neovascularization in age-related macular degeneration with verteporfin: two-year results of 2 randomized clinical trials-tap report 2.
Bressler NM;
Arch Ophthalmol; 2001 Feb; 119(2):198-207. PubMed ID: 11176980
[TBL] [Abstract][Full Text] [Related]
19. Combined photodynamic therapy and intravitreal triamcinolone injection for the treatment of subfoveal choroidal neovascularisation in age related macular degeneration: a comparative study.
Chan WM; Lai TY; Wong AL; Tong JP; Liu DT; Lam DS
Br J Ophthalmol; 2006 Mar; 90(3):337-41. PubMed ID: 16488958
[TBL] [Abstract][Full Text] [Related]
20. Photodynamic therapy with verteporfin for choroidal neovascularization associated with retinal pigment epithelial detachment in age-related macular degeneration.
Pece A; Isola V; Vadalà M; Calori G
Retina; 2007 Mar; 27(3):342-8. PubMed ID: 17460590
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
